Immunologic Detection of Occult Primary Cancer of the Head and Neck
- 1 March 1981
- journal article
- research article
- Published by Wiley in Otolaryngology -- Head and Neck Surgery
- Vol. 89 (2) , 230-234
- https://doi.org/10.1177/019459988108900217
Abstract
Because antibody titers against Epstein-Barr virus (EBV) antigens often are elevated in patients with active undifferentiated and nonkeratinizing nasopharyngeal carcinoma, anti-EBV serologic tests have been applied as a diagnostic aid in patients who have metastatic lymphadenopathy in the neck without an obvious source. In this study of 44 patients, the serologic testing procedure proved useful in identifying six patients with nasopharyngeal carcinoma that was initially occult but was eventually confirmed by biopsy.Keywords
This publication has 6 references indexed in Scilit:
- Anti‐EBV serologic tests for nasopharyngeal carcinomaThe Laryngoscope, 1980
- Epstein-Barr Virus-Associated Antigens in Nasopharyngeal Carcinoma: Relation to Clinical Course of American PatientsJAMA Otolaryngology–Head & Neck Surgery, 1978
- An immunologic basis for detection of occult primary malignancies of the head and neckCancer, 1978
- SERUM IgA ANTIBODIES TO EPSTEIN-BARR VIRUS CAPSID ANTIGEN PRECEDING SYMPTOMS OF NASOPHARYNGEAL CARCINOMAPublished by Elsevier ,1978
- Epstein‐barr virus‐specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinomaInternational Journal of Cancer, 1976
- Metastatic carcinoma in cervical nodes with an unknown primary lesionThe American Journal of Surgery, 1966